CLARA GOODMAN: Open Payments
NPI 1003589383 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 56 payments from 18 companies in 2025. Trend: 2023 $310 · 2024 $380 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $248 |
| AstraZeneca Pharmaceuticals LP | 9 | $163 |
| Lilly USA, LLC | 5 | $102 |
| Astellas Pharma US Inc | 4 | $100 |
| PFIZER INC. | 4 | $70 |
| Novo Nordisk Inc | 3 | $54 |
| Inspire Medical Systems, Inc. | 1 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $33 |
| SpringWorks Therapeutics, Inc. | 1 | $26 |
Products named: VRAYLAR, MOUNJARO, AIRSUPRA, QULIPTA, Veozah, BREZTRI, INSPIRE, UBRELVY.
Industry payments across AZ — which companies pay providers there.
